Phase 4 Multiple Sclerosis Clinical Trials
13 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–13 of 13 trials
Recruiting
Phase 4
Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remitting
Northwestern University40 enrolled1 locationNCT07225361
Recruiting
Phase 4
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Ocrelizumab in Participants With Relapsing Multiple Sclerosis and Primary Progressive Multiple Sclerosis
Relapsing Multiple SclerosisPrimary Progressive Multiple Sclerosis
Hoffmann-La Roche60 enrolled17 locationsNCT07483450
Recruiting
Phase 4
Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis
Multiple Sclerosis
Novartis Pharmaceuticals30 enrolled6 locationsNCT04480853
Recruiting
Phase 4
Dalfampridine Combined With Physical Therapy for Mobility Impairment in Multiple Sclerosis
Multiple Sclerosis
MGH Institute of Health Professions48 enrolled1 locationNCT06136728
Recruiting
Phase 4
Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis
Multiple Sclerosis
Novartis Pharmaceuticals20 enrolled22 locationsNCT06444113
Recruiting
Phase 4
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)123 enrolled12 locationsNCT05285891
Recruiting
Phase 4
Glucose Consumption in MS Using [F-18]FDG-PET
Multiple Sclerosis
Brigham and Women's Hospital50 enrolled1 locationNCT07087106
Recruiting
Phase 4
Individualised Cryoneurolysis to Treat Pain in the Context of Spasticity in the Upper and Lower Extremities
Multiple SclerosisSpinal Cord InjuryCentreal Neurological Condition+1 more
Oxford University Hospitals NHS Trust50 enrolled1 locationNCT07303582
Recruiting
Phase 4
ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS
Relapsing-remitting Multiple Sclerosis (RRMS)
Novartis Pharmaceuticals224 enrolled11 locationsNCT06733922
Recruiting
Phase 4
Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod
Relapsing Multiple Sclerosis
University of Colorado, Denver100 enrolled3 locationsNCT06529406
Recruiting
Phase 4
Effects of Ocrelizumab Treatment on Immune Cells in Lymph Nodes in Multiple Sclerosis
Multiple Sclerosis, Relapsing-Remitting
University of California, San Francisco5 enrolled1 locationNCT06495593
Recruiting
Phase 4
B Cell Tailored Ocrelizumab Versus Standard Ocrelizumab in Relapsing Remitting Multiple Sclerosis
Multiple Sclerosis, Relapsing-Remitting
Amsterdam UMC, location VUmc296 enrolled1 locationNCT05296161
Recruiting
Phase 4
Home Based Infusions for Ocrelizumab
Multiple Sclerosis
University of Colorado, Denver110 enrolled1 locationNCT04650321